BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20306296)

  • 1. Predictive models for nucleoside bisubstrate analogs as inhibitors of siderophore biosynthesis in Mycobacterium tuberculosis: pharmacophore mapping and chemometric QSAR study.
    Tawari NR; Degani MS
    Mol Divers; 2011 May; 15(2):435-44. PubMed ID: 20306296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine.
    Neres J; Labello NP; Somu RV; Boshoff HI; Wilson DJ; Vannada J; Chen L; Barry CE; Bennett EM; Aldrich CC
    J Med Chem; 2008 Sep; 51(17):5349-70. PubMed ID: 18690677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR studies and shape based virtual screening for identification of novel hits to inhibit MbtA in Mycobacterium tuberculosis.
    Maganti L; ; Ghoshal N
    J Biomol Struct Dyn; 2015; 33(2):344-64. PubMed ID: 24417439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis.
    Somu RV; Boshoff H; Qiao C; Bennett EM; Barry CE; Aldrich CC
    J Med Chem; 2006 Jan; 49(1):31-4. PubMed ID: 16392788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore modeling and density functional theory analysis for a series of nitroimidazole compounds with antitubercular activity.
    Tawari NR; Degani MS
    Chem Biol Drug Des; 2011 Sep; 78(3):408-17. PubMed ID: 21689377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain.
    Somu RV; Wilson DJ; Bennett EM; Boshoff HI; Celia L; Beck BJ; Barry CE; Aldrich CC
    J Med Chem; 2006 Dec; 49(26):7623-35. PubMed ID: 17181146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosis.
    Krajczyk A; Zeidler J; Januszczyk P; Dawadi S; Boshoff HI; Barry CE; Ostrowski T; Aldrich CC
    Bioorg Med Chem; 2016 Jul; 24(14):3133-43. PubMed ID: 27265685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
    Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ
    J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.
    Engelhart CA; Aldrich CC
    J Org Chem; 2013 Aug; 78(15):7470-81. PubMed ID: 23805993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis.
    Nelson KM; Viswanathan K; Dawadi S; Duckworth BP; Boshoff HI; Barry CE; Aldrich CC
    J Med Chem; 2015 Jul; 58(14):5459-75. PubMed ID: 26110337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis.
    Gupte A; Boshoff HI; Wilson DJ; Neres J; Labello NP; Somu RV; Xing C; Barry CE; Aldrich CC
    J Med Chem; 2008 Dec; 51(23):7495-507. PubMed ID: 19053762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Structure-Activity Relationship Study of Naphthoquinone Derivatives as Antitubercular Agents Using Molecular Modeling Techniques.
    Sharma MC
    Interdiscip Sci; 2015 Dec; 7(4):346-56. PubMed ID: 26159131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the Structural Requirements of Nucleoside Bisubstrate Analogues for Inhibition of MbtA in Mycobacterium tuberculosis: A FB-QSAR Study and Combinatorial Library Generation for Identifying Potential Hits.
    Maganti L; Das SK; Mascarenhas NM; Ghoshal N
    Mol Inform; 2011 Oct; 30(10):863-72. PubMed ID: 27468106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a selective activity-based probe for adenylating enzymes: profiling MbtA Involved in siderophore biosynthesis from Mycobacterium tuberculosis.
    Duckworth BP; Wilson DJ; Nelson KM; Boshoff HI; Barry CE; Aldrich CC
    ACS Chem Biol; 2012 Oct; 7(10):1653-8. PubMed ID: 22796950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.
    Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
    Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.